Shopping Cart
Remove All
Your shopping cart is currently empty
Elritercept (KER-050) is a recombinant fusion protein composed of a modified extracellular domain of the activin receptor type IIA fused to human IgG1 Fc. It functions by inhibiting activin A and other specific ligands of the TGF-β superfamily.

| Description | Elritercept (KER-050) is a recombinant fusion protein composed of a modified extracellular domain of the activin receptor type IIA fused to human IgG1 Fc. It functions by inhibiting activin A and other specific ligands of the TGF-β superfamily. |
| Synonyms | KER-050 |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | < 1.0 EU/mg |
| Conjucates | Unconjugated |
| Cas No. | 2727114-26-1 |
| Storage | store at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.